SPY
773.04
+0.16%
QQQ
727.81
−0.03%
BTC/USD
82,226.32
+0.12%
DIA
521.18
GLD
382.61
−0.03%
TLT
79.74
−0.29%
US
Sign in
Register
My Account
Benzinga
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Lakefront Biotherapeutics NV Unusual Options
LKFT
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$29.93
0.53
1.8%
Get Report
Overview
News
Earnings Forecast
Events
Price Targets
Financials
Sentiment
Compare
Stock Report
Privacy Manager
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
M&A:
Lakefront Biotherapeutics (LKFT) sold assets to Armed Cell Therapeutics BV on Wednesday, October 14, 2026 for €8M
Options
Unusual Options Activity
No Unusual Options Activity in the Last 90 Days